Form 4: Tenaya Therapeutics Chief Medical Officer Sells Shares to Cover Tax Obligations

Whittemore Tingley, Chief Medical Officer of Tenaya Therapeutics, sold shares of common stock on March 10, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 10, 2025, Whittemore Tingley, the Chief Medical Officer of Tenaya Therapeutics, sold shares of the company's common stock.
• The sales were executed in multiple transactions at a weighted average price of $0.5384 per share.
• A total of 1,727 shares were sold to cover tax obligations related to restricted stock units awarded on February 15, 2023.
• An additional 4,073 shares were sold to cover tax obligations related to restricted stock units.
• Another 1,598 shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
• Following these transactions, Tingley directly owns 174,793 shares of Tenaya Therapeutics common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine sale of shares to cover tax obligations, which doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The stock sale by a company insider could have a minor negative impact on shareholder sentiment, but is unlikely to have a significant long-term effect.

Key Dates